News Breaks |
|
|
| January 8, 2013 |
| 12:09 EDT |  | AMGN | Amgen says R&D tax credit wont be reflected in 2012 results
|
|
|
News For AMGN From The Last 14 Days Check below for free stories on AMGN the last two weeks. |
|
|
| June 18, 2013 |
| 19:07 EDT | | AMGN | On The Fly: After Hours Movers
 Subscribe for More Information |
|
| 17:25 EDT | | AMGN | Amgen reports 7.58% stake in Cytokinetics
Subscribe for More Information |
|
| June 16, 2013 |
| 11:44 EDT |  | AMGN | Amgen still looks attractive, Barron's says
Subscribe for More Information |
|
| June 13, 2013 |
| 11:06 EDT | | AMGN | FDA approves Xgeva to treat giant cell tumor of the bone
Subscribe for More Information |
|
| 11:04 EDT | | AMGN | FDA approves Xgeva to treat giant cell tumor of the bone
Subscribe for More Information |
|
| 07:32 EDT |  | AMGN | European League Against Rheumatism to host annual meeting
Subscribe for More Information |
|
| June 12, 2013 |
| 09:13 EDT | | AMGN | Amgen, AstraZeneca to advance brodalumab into Phase 3 studies
Subscribe for More Information |
|
| 09:04 EDT | | AMGN | Amgen announces positive top-line results of Phase 3 trebananib
Subscribe for More Information |
|
| 07:39 EDT | | AMGN | Amgen, Cytokinetics announce expansion of license for omecamtiv mecarbil
Subscribe for More Information |
|
| June 11, 2013 |
| 07:31 EDT | | AMGN | Goldman to host a conference
Subscribe for More Information |
| |
| June 10, 2013 |
| 07:40 EDT | | AMGN | Leerink's biotech analyst holds analyst/industry conference call on ASCO
Subscribe for More Information |
|
| 07:20 EDT | | AMGN | Biomed to host a conference
Subscribe for More Information |
|
|
|
|
|
